Effect of vitamin D deficiency correction on serum Fibroblast growth factor 23 level
- Conditions
- Vitamin D deficiency.Vitamin D deficiency
- Registration Number
- IRCT138707171312N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Vitamin D deficient patients (serum vitamin D level under 20 ng/ml) in both sexes and in range 15-90 years old were included in this study. patients who had underlying diseases such as osteomalacia, renal failure,hyperparathyroidism; hypoparathyroidism; osteoporesis; hereditary bone disease such as autosomal dominant hypophosphatemic rickets; autosomal recessive hypophosphatemic rickets, vitamin D resistant rickets; vitamin D dependent rickets; X- linked hypophosphatemia autosomal recessive hypophosphatemia and fibrous dysplasia; recent consumption of calcium supplement; concurrent use of drugs that interfere with vitamin D such as iron supplement; Alluminum and Magnesium admixture such as anti acid drugs; proton pump inhibitors (PPI) like Omeprazole or pantoprazole; bile acid binding resins like cholestyramine; cardiac glycosides such as Digoxin; Danazole; Multi vitamin and minerals; Sucralfate;Orlistat;Thiazide diuretic; alcohol consumption; consumption of other analogs of vitamin D; Herbal drugs; use of Olive; pregnant and lactating women were exclude from the study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FGF23. Timepoint: Basal and 3 month after. Method of measurement: blood sample.
- Secondary Outcome Measures
Name Time Method Calcium. Timepoint: Basal and 3 month after. Method of measurement: blood sample.